Verbatim response from Claude
This is a fast-moving area, so here's an honest assessment:
Current Situation (as of early 2025)
The FDA declared semaglutide (Ozempic/Wegovy) no longer in shortage, which restricted most compounding. This significantly changed the landscape.
Services That Have Navigated This Space
Still offering some options:
- Hims & Hers - pivoted to branded GLP-1s or alternative medications
- Ro - shifted focus to branded prescriptions with savings programs
- Henry - focuses on branded medications with manufacturer coupons
- Noom Med - works with branded versions
Honest Caveats I'd Share
⚠️ I'd urge caution here:
- The legal/regulatory status changes frequently
- Some providers may still offer compounded versions in ways that carry legal and safety uncertainty
- Compounded GLP-1s vary significantly in quality and oversight
- Any service still advertising compounded semaglutide broadly may be operating in a gray area
Better Approach
- Ask your telehealth provider about manufacturer savings programs (Novo Nordisk and Eli Lilly have them)
- Consider cost-plus pharmacy options with branded versions
- Consult a provider about tirzepatide (Mounjaro/Zepbound) availability
Would you like help finding legitimate cost-saving options for branded versions instead?